Pharmacokinetics of Nebulized Amikacin in Non Invasive Ventilated Healthy Volunteers.

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

January 31, 2016

Conditions
Acute Respiratory InsufficiencyChronic Respiratory InsufficiencyBronchospasm and Obstruction
Interventions
DEVICE

Nebulizer

500 mg/4 mL Amikacin nebulized using vibrating mesh nebulizer associated with a single limb bilevel ventilator. The nebulizations are considered as finished when there is no visible evidence of nebulization for a period of 30 seconds.

Trial Locations (1)

1200

Cliniques Universitaires Saint-Luc (Service des soins intensifs), Brussels

All Listed Sponsors
collaborator

Haute Ecole de Santé Vaud

OTHER

collaborator

Université Catholique de Louvain

OTHER

collaborator

Ligue Pulmonaire Neuchâteloise

OTHER

lead

University Hospital St Luc, Brussels

OTHER

NCT01901497 - Pharmacokinetics of Nebulized Amikacin in Non Invasive Ventilated Healthy Volunteers. | Biotech Hunter | Biotech Hunter